Connie Darmanin
Connie Darmanin
Verified email at latrobe.edu.au
Title
Cited by
Cited by
Year
Aldose reductase structures: implications for mechanism and inhibition
O El-Kabbani, F Ruiz, C Darmanin, RPT Chung
Cellular and Molecular Life Sciences CMLS 61 (7-8), 750-762, 2004
1222004
Ultrahigh resolution drug design. II. Atomic resolution structures of human aldose reductase holoenzyme complexed with Fidarestat and Minalrestat: implications for the binding …
O El‐Kabbani, C Darmanin, TR Schneider, I Hazemann, F Ruiz, M Oka, ...
Proteins: Structure, Function, and Bioinformatics 55 (4), 805-813, 2004
872004
Structure of aldehyde reductase holoenzyme in complex with the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity
O El-Kabbani, V Carbone, C Darmanin, M Oka, A Mitschler, A Podjarny, ...
Journal of medicinal chemistry 48 (17), 5536-5542, 2005
622005
Sorbitol dehydrogenase: structure, function and ligand design
O El-Kabbani, C Darmanin, RPT Chung
Current medicinal chemistry 11 (4), 465-476, 2004
622004
Megahertz serial crystallography
MO Wiedorn, D Oberthür, R Bean, R Schubert, N Werner, B Abbey, ...
Nature communications 9 (1), 1-11, 2018
612018
Hematin− hematin self-association states involved in the formation and reactivity of the malaria parasite pigment, hemozoin
N Klonis, R Dilanian, E Hanssen, C Darmanin, V Streltsov, S Deed, ...
Biochemistry 49 (31), 6804-6811, 2010
612010
Incorporation of the dopamine D2L receptor and bacteriorhodopsin within bicontinuous cubic lipid phases. 1. Relevance to in meso crystallization of integral membrane proteins …
CE Conn, C Darmanin, SM Sagnella, X Mulet, TL Greaves, JN Varghese, ...
Soft Matter 6 (19), 4828-4837, 2010
372010
Structure of human aldose reductase holoenzyme in complex with Statil: An approach to structure‐based inhibitor design of the enzyme
O El‐Kabbani, P Ramsland, C Darmanin, RPT Chung, A Podjarny
Proteins: Structure, Function, and Bioinformatics 50 (2), 230-238, 2003
342003
Incorporation of the dopamine D2L receptor and bacteriorhodopsin within bicontinuous cubic lipid phases. 2. Relevance to in meso crystallization of integral membrane proteins …
CE Conn, C Darmanin, SM Sagnella, X Mulet, TL Greaves, JN Varghese, ...
Soft Matter 6 (19), 4838-4846, 2010
332010
High-throughput production and structural characterization of libraries of self-assembly lipidic cubic phase materials
C Darmanin, CE Conn, J Newman, X Mulet, SA Seabrook, YL Liang, ...
ACS combinatorial science 14 (4), 247-252, 2012
312012
High-throughput analysis of the structural evolution of the monoolein cubic phase in situ under crystallogenesis conditions
CE Conn, C Darmanin, X Mulet, S Le Cann, N Kirby, CJ Drummond
Soft Matter 8 (7), 2310-2321, 2012
312012
High-resolution structures of human aldose reductase holoenzyme in complex with stereoisomers of the potent inhibitor Fidarestat: stereospecific interaction between the enzyme …
O El-Kabbani, C Darmanin, M Oka, C Schulze-Briese, T Tomizaki, ...
Journal of medicinal chemistry 47 (18), 4530-4537, 2004
292004
Enhanced uptake of an integral membrane protein, the dopamine D2L receptor, by cubic nanostructured lipid nanoparticles doped with Ni (II) chelated EDTA amphiphiles
CE Conn, X Mulet, MJ Moghaddam, C Darmanin, LJ Waddington, ...
Soft Matter 7 (2), 567-578, 2011
282011
Effect of lipid architecture on cubic phase susceptibility to crystallisation screens
CE Conn, C Darmanin, X Mulet, A Hawley, CJ Drummond
Soft Matter 8 (26), 6884-6896, 2012
272012
Crystal structure of human L‐xylulose reductase holoenzyme: Probing the role of Asn107 with site‐directed mutagenesis
O El‐Kabbani, S Ishikura, C Darmanin, V Carbone, RPT Chung, N Usami, ...
Proteins: Structure, Function, and Bioinformatics 55 (3), 724-732, 2004
272004
Modelling studies on the binding of substrate and inhibitor to the active site of human sorbitol dehydrogenase
C Darmanin, O El-Kabbani
Bioorganic & medicinal chemistry letters 10 (10), 1101-1104, 2000
252000
Modelling studies of the active site of human sorbitol dehydrogenase: an approach to structure-based inhibitor design of the enzyme
C Darmanin, O El-Kabbani
Bioorganic & medicinal chemistry letters 11 (24), 3133-3136, 2001
242001
In meso crystallization: compatibility of different lipid bicontinuous cubic mesophases with the cubic crystallization screen in aqueous solution
L van’t Hag, C Darmanin, TC Le, S Mudie, CE Conn, CJ Drummond
Crystal growth & design 14 (4), 1771-1781, 2014
212014
Structure of the tetrameric form of human L‐Xylulose reductase: Probing the inhibitor‐binding site with molecular modeling and site‐directed mutagenesis
O El‐Kabbani, V Carbone, C Darmanin, S Ishikura, A Hara
Proteins: Structure, Function, and Bioinformatics 60 (3), 424-432, 2005
202005
Probing the ultra-high resolution structure of aldose reductase with molecular modelling and noncovalent mass spectrometry
C Darmanin, G Chevreux, N Potier, A Van Dorsselaer, I Hazemann, ...
Bioorganic & medicinal chemistry 12 (14), 3797-3806, 2004
192004
The system can't perform the operation now. Try again later.
Articles 1–20